Your browser doesn't support javascript.
loading
Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer.
Lin, Ruo-Kai; Su, Chih-Ming; Lin, Shih-Yun; Thi Anh Thu, Le; Liew, Phui-Ly; Chen, Jian-Yu; Tzeng, Huey-En; Liu, Yun-Ru; Chang, Tzu-Hao; Lee, Cheng-Yang; Hung, Chin-Sheng.
Affiliation
  • Lin RK; Program in Drug Discovery and Development Industry, Program in Clinical Drug Development of Herbal Medicine, Master Program in Clinical Genomics and Proteomics, College of Pharmacy, Graduate Institute of Pharmacognosy, Taipei Medical University, 250 Wu-Hsing Street, Taipei, Taiwan.
  • Su CM; Clinical Trial Center, Taipei Medical University Hospital, 252 Wu-Hsing Street, Taipei, Taiwan.
  • Lin SY; Division of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
  • Thi Anh Thu L; Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Liew PL; Program in Drug Discovery and Development Industry, Program in Clinical Drug Development of Herbal Medicine, Master Program in Clinical Genomics and Proteomics, College of Pharmacy, Graduate Institute of Pharmacognosy, Taipei Medical University, 250 Wu-Hsing Street, Taipei, Taiwan.
  • Chen JY; Quang Tri Medical College, Dien Bien Phu Str., Dong Luong District, Dong Ha City, Quang Tri, Vietnam.
  • Tzeng HE; Department of Pathology, Shuang Ho Hospital, Taipei Medical University, New Taipei, Taiwan.
  • Liu YR; Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Chang TH; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
  • Lee CY; Division of Hematology and Oncology, Department of Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
  • Hung CS; Department of Medical Research, Division of Hematology/Medical Oncology, Department of Medicine, Taichung Veterans General Hospital, Taichung City, Taiwan.
Mol Med ; 28(1): 67, 2022 06 17.
Article in En | MEDLINE | ID: mdl-35715741
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Agents, Hormonal / DNA Methylation / Membrane Proteins Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2022 Document type: Article Affiliation country: Taiwán Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Agents, Hormonal / DNA Methylation / Membrane Proteins Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2022 Document type: Article Affiliation country: Taiwán Country of publication: Reino Unido